Snorers and their long suffering partners and families will sleep and breathe much more easily in 2014 and beyond with the launch of an innovative snoring control product.
Researchers and clinicians agree that, as we age and gain weight, snoring becomes a major problem to huge numbers of people. Experts are calling it a global epidemic.
Snoring happens because of the relaxation of two muscles, the tongue and the muscle which controls the lower jaw. When they relax, gravity takes over and the tongue, which is attached to the lower jaw, moves back until it contacts the soft palate to partially or completely block the airway. With partial blocking, as air is forced past the blockage the soft palate vibrates producing the familiar snoring noise.
If the airway is blocked completely the sufferer stops breathing altogether until the need for air actually wakes him or her from sleep. This is known as Obstructive Sleep Apnoea, a condition so serious it is known to affect the sufferer’s general health to the point of significantly shortening his or her lifespan. The good folk at the highly respected Mayo Clinic in Minnesota believe (and are in the process of proving) that otherwise healthy people who die in their sleep do so as a direct result of Obstructive Sleep Apnoea.
Even mild snoring is known to have a detrimental effect on the general health and wellbeing of the sufferer. The oxygen deprivation that results from snoring and OSA can affect hormonal function, the immune system and the circulatory system. This in turn can lead to weight gain, depression, insomnia, heart disease, stroke, type 2 diabetes, cancer, high blood pressure and erectile dysfunction in men.
Oxygen deprivation is also an indicator in the onset of Dementia. A research team from the University of California, San Francisco, carried out a study involving almost 300 women with an average age of 82 years who did not have dementia.
The women were given medical tests for breathing disorders during sleep, which measured the number of times their breathing was interrupted or briefly ceased while they were asleep, and levels of oxygen deprivation, or hypoxia, in the brain.
One-third met the criteria for sleep-disordered breathing.
After more than four years of follow-up, 36 per cent of the women developed mild cognitive impairment or dementia.
Forty-seven women (45 per cent) with prevalent sleep-disordered breathing developed mild cognitive impairment or dementia compared with 31 per cent of those without sleep-disordered breathing – an increase of 50 per cent in the numbers affected.
Analysis of the data indicated that the presence of sleep-disordered breathing was associated with an increased odds of subsequent mild cognitive impairment or dementia.
The researchers also found that two measures of hypoxia were associated with higher incidence of mild cognitive impairment or dementia.
But the amount of sleep fragmentation or lack of sleep were not associated with risk of cognitive impairment.
All this means that over the years many attempts have been made to come up with a solution to the problem, but the perfect solution which “ticked all the boxes” has remained elusive.
The few products that actually do work are either too expensive, too obtrusive or too uncomfortable to use to the point of being harmful.
But now we have The Silent Treatment. Made in New Zealand, this product works in a completely different way from all the others, and it does indeed “tick all the boxes”.
For more information visit www.quitsnoring.co